These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 11472885)
1. Levormeloxifene prevents increased bone turnover and vertebral bone loss following ovariectomy in cynomolgus monkeys. Hotchkiss CE; Stavisky R; Nowak J; Brommage R; Lees CJ; Kaplan J Bone; 2001 Jul; 29(1):7-15. PubMed ID: 11472885 [TBL] [Abstract][Full Text] [Related]
2. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys. Jerome CP; Power RA; Obasanjo IO; Register TC; Guidry M; Carlson CS; Weaver DS Bone; 1997 Apr; 20(4):355-64. PubMed ID: 9108356 [TBL] [Abstract][Full Text] [Related]
3. Minodronic acid ameliorates vertebral bone strength by increasing bone mineral density in 9-month treatment of ovariectomized cynomolgus monkeys. Tanaka M; Mori H; Kawabata K; Mashiba T Bone; 2016 Jul; 88():157-164. PubMed ID: 27155564 [TBL] [Abstract][Full Text] [Related]
4. Effects of a new selective estrogen receptor modulator (MDL 103,323) on cancellous and cortical bone in ovariectomized ewes: a biochemical, histomorphometric, and densitometric study. Chavassieux P; Garnero P; Duboeuf F; Vergnaud P; Brunner-Ferber F; Delmas PD; Meunier PJ J Bone Miner Res; 2001 Jan; 16(1):89-96. PubMed ID: 11149494 [TBL] [Abstract][Full Text] [Related]
5. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model. Lee YS; Gupta R; Kwon JT; Cho DC; Seo YJ; Seu SY; Park EK; Han I; Kim CH; Sung JK; Kim KT Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000 [TBL] [Abstract][Full Text] [Related]
6. Reductions in bone mass, structure, and strength in axial and appendicular skeletons associated with increased turnover after ovariectomy in mature cynomolgus monkeys and preventive effects of clodronate. Itoh F; Kojima M; Furihata-Komatsu H; Aoyagi S; Kusama H; Komatsu H; Nakamura T J Bone Miner Res; 2002 Mar; 17(3):534-43. PubMed ID: 11874245 [TBL] [Abstract][Full Text] [Related]
7. Effects of 16-month treatment with the cathepsin K inhibitor ONO-5334 on bone markers, mineral density, strength and histomorphometry in ovariectomized cynomolgus monkeys. Yamada H; Ochi Y; Mori H; Nishikawa S; Hashimoto Y; Nakanishi Y; Tanaka M; Bruce M; Deacon S; Kawabata K Bone; 2016 May; 86():43-52. PubMed ID: 26921823 [TBL] [Abstract][Full Text] [Related]
8. Effects of lasofoxifene on bone in surgically postmenopausal cynomolgus monkeys. Lees C; Shen V; Brommage R Menopause; 2007; 14(1):97-105. PubMed ID: 17075430 [TBL] [Abstract][Full Text] [Related]
9. What can be learned from the levormeloxifene experience? Ravn P; Nielsen TF; Christiansen C Acta Obstet Gynecol Scand; 2006; 85(2):135-42. PubMed ID: 16532904 [TBL] [Abstract][Full Text] [Related]
10. The effects of bazedoxifene in the ovariectomized aged cynomolgus monkey. Smith SY; Jolette J; Chouinard L; Komm BS J Bone Miner Metab; 2015 Mar; 33(2):161-72. PubMed ID: 24633538 [TBL] [Abstract][Full Text] [Related]
11. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys. Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565 [TBL] [Abstract][Full Text] [Related]
12. Short- and long-term effects of calcium and exercise on bone mineral density in ovariectomized rats. Gala J; Díaz-Curiel M; de la Piedra C; Calero J Br J Nutr; 2001 Oct; 86(4):521-7. PubMed ID: 11591240 [TBL] [Abstract][Full Text] [Related]
13. Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM). Christgau S; Tankó LB; Cloos PA; Mouritzen U; Christiansen C; Delaissé JM; Høegh-Andersen P Menopause; 2004; 11(5):508-18. PubMed ID: 15356403 [TBL] [Abstract][Full Text] [Related]
14. Influence of ovariectomy on bone turnover and trabecular bone mass in mature cynomolgus monkeys. Iwamoto J; Seki A; Matsuura M; Sato Y; Takeda T; Matsumoto H; Yeh JK Yonsei Med J; 2009 Jun; 50(3):358-67. PubMed ID: 19568597 [TBL] [Abstract][Full Text] [Related]
15. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats. Ke HZ; Crawford DT; Qi H; Pirie CM; Simmons HA; Chidsey-Frink KL; Chen HK; Jee WS; Thompson DD Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783 [TBL] [Abstract][Full Text] [Related]
16. Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey. Müller R; Hannan M; Smith SY; Bauss F J Bone Miner Res; 2004 Nov; 19(11):1787-96. PubMed ID: 15476578 [TBL] [Abstract][Full Text] [Related]
17. Effects on bone of oral hormone replacement therapy initiated 2 years after ovariectomy in young adult monkeys. Jayo MJ; Register TC; Carlson CS Bone; 1998 Oct; 23(4):361-6. PubMed ID: 9763148 [TBL] [Abstract][Full Text] [Related]
18. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption. Doyle N; Varela A; Haile S; Guldberg R; Kostenuik PJ; Ominsky MS; Smith SY; Hattersley G Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289 [TBL] [Abstract][Full Text] [Related]
19. Effects of raloxifene on bone density, biomarkers, and histomorphometric and biomechanical measures in ovariectomized cynomolgus monkeys. Lees CJ; Register TC; Turner CH; Wang T; Stancill M; Jerome CP Menopause; 2002; 9(5):320-8. PubMed ID: 12218720 [TBL] [Abstract][Full Text] [Related]
20. Three-dimensional modeling of the effects of parathyroid hormone on bone distribution in lumbar vertebrae of ovariectomized cynomolgus macaques. Sato M; Westmore M; Clendenon J; Smith S; Hannum B; Zeng GQ; Brommage R; Turner CH Osteoporos Int; 2000; 11(10):871-80. PubMed ID: 11199192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]